| Biotechnology Industry | Healthcare Sector | Mr. Baohua Cheng CEO | XSHE Exchange | CNE100005774 ISIN |
| CN Country | 436 Employees | 16 Jul 2026 Last Dividend | 17 Jun 2022 Last Split | - IPO Date |
Shandong Sanyuan Biotechnology Co.,Ltd., founded in 2007 and based in Binzhou, China, operates in the biotechnology industry, focusing on the research and development, production, and sales of erythritol and compound sugar products. The company has established a significant presence, not only within China but also on a global scale, exporting its products to various regions, including Europe, the United States, East Asia, Southeast Asia, Australia, New Zealand, and Africa. Shandong Sanyuan Biotechnology Co.,Ltd. has positioned itself as a key player in the market for erythritol, compound sugars, and related biotechnological products.
Shandong Sanyuan Biotechnology Co.,Ltd. offers an extensive range of products, catering to diverse industries. These include: